Gilles Avenard
Founder presso ACTICOR BIOTECH SAS
Provenienza dei contatti di primo grado di Gilles Avenard
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
27
| Non-Profit Organization | Miscellaneous Commercial Services | 27 |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Biotechnology | 20 | |
Hoechst Marion Roussel SA
5
| Extinct | Pharmaceuticals: Other | 5 |
| Public Company | Agricultural Commodities/Milling | 5 | |
Minka Therapeutics SA
 Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gilles Avenard tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ATON | Pharmaceuticals: Major | Chairman Human Resources Officer Director of Finance/CFO | |
Altavia France SA
 Altavia France SA Advertising/Marketing ServicesCommercial Services Altavia France SA is an investment holding company with interest in marketing and advertising sector. The company was founded on September 1, 1954 and is headquartered in Saint-Ouen-Sur-Seine, France. | Advertising/Marketing Services | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chairman Director/Board Member | |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member Director/Board Member | |
| THERADIAG | Medical Specialties | Director/Board Member Director/Board Member Chairman Chief Executive Officer Chairman | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| EM Lyon Business School | College/University | Undergraduate Degree Undergraduate Degree | |
| École Normale Supérieure | College/University | Doctorate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin | |
| University of Strasbourg | College/University | Doctorate Degree Doctorate Degree | |
Biotechnological Enzymatic Catalyse NV
 Biotechnological Enzymatic Catalyse NV Food: Major DiversifiedConsumer Non-Durables Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium. | Food: Major Diversified | Director/Board Member Director/Board Member | |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Université Catholique de Louvain | College/University | Doctorate Degree Graduate Degree | |
| AB SCIENCE | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| DEINOVE | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Graftys SA
 Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Founder Director/Board Member | |
Ridoret Distribution SARL
 Ridoret Distribution SARL Wholesale DistributorsDistribution Services Ridoret Distribution SARL provides carpentry services. It specializes in doors and windows. The firm also provides client consulting. The company was founded on November 16, 1982 and is headquartered in La Rochelle, France. | Wholesale Distributors | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| AMOÉBA | Household/Personal Care | Director/Board Member Director/Board Member | |
| ADVICENNE | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Key Neurosciences SAS provides research and development services. Its services include product and technology development, fund raising, business and commercial development, and project management. The company was founded in December 2010 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| THERANEXUS | Pharmaceuticals: Major | Director/Board Member Founder | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
| Roche SAS | President Corporate Officer/Principal | ||
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Founder Director/Board Member | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Director/Board Member |
Statistiche
Distribuzione geografica
| Francia | 44 |
| Paesi Bassi | 3 |
| Belgio | 3 |
| Danimarca | 2 |
| Svezia | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Consumer Non-Durables | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 335 |
| Corporate Officer/Principal | 95 |
| Chairman | 83 |
| Chief Executive Officer | 66 |
| Independent Dir/Board Member | 43 |
Contatti più connessi
| Insiders | |
|---|---|
| Alain Munoz | 38 |
| Rémi Droller | 29 |
| Alain Parthoens | 29 |
| Pierre Armand Morgon | 29 |
| Franck Lescure | 28 |
| Michel Arié | 25 |
| Catherine Dunand | 23 |
| Corinne Le Goff | 19 |
| Jean-François Labbé | 18 |
| Catherine Boule | 18 |
| Denis Biju-Duval | 18 |
| Piers John Morgan | 18 |
| Guy Heynen | 17 |
| Marc Le Bozec | 16 |
| Michel Finance | 15 |
- Borsa valori
- Insiders
- Gilles Avenard
- Connessioni Società
